# NCCNè‚¿ç˜¤å­¦ä¸´åºŠå®è·µæŒ‡å—ç›®å½•

NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) are posted with the latest update date and version number.

## æ¦‚è¦æ€»ç»“

NCCNä¸´åºŠå®è·µæŒ‡å—æ¶µç›–äº†67ç§ç™Œç—‡ç±»å‹ï¼ŒæŒ‰ç³»ç»Ÿåˆ†ç±»å¦‚ä¸‹ï¼š

- **è¡€æ¶²ç³»ç»Ÿè‚¿ç˜¤**ï¼š15ç§ï¼ˆåŒ…æ‹¬å„ç±»ç™½è¡€ç—…ã€æ·‹å·´ç˜¤ã€éª¨é«“ç˜¤ç­‰ï¼‰
- **æ¶ˆåŒ–ç³»ç»Ÿè‚¿ç˜¤**ï¼š11ç§ï¼ˆåŒ…æ‹¬èƒƒç™Œã€ç»“ç›´è‚ ç™Œã€è‚ç™Œã€èƒ°è…ºç™Œç­‰ï¼‰
- **å¦‡ç§‘è‚¿ç˜¤**ï¼š6ç§ï¼ˆåŒ…æ‹¬å®«é¢ˆç™Œã€åµå·¢ç™Œã€å­å®«å†…è†œç™Œç­‰ï¼‰
- **æ³Œå°¿ç”Ÿæ®–ç³»ç»Ÿè‚¿ç˜¤**ï¼š6ç§ï¼ˆåŒ…æ‹¬å‰åˆ—è…ºç™Œã€è‚¾ç™Œã€è†€èƒ±ç™Œç­‰ï¼‰
- **è‚ºéƒ¨è‚¿ç˜¤**ï¼š2ç§ï¼ˆéå°ç»†èƒè‚ºç™Œã€å°ç»†èƒè‚ºç™Œï¼‰
- **çš®è‚¤è‚¿ç˜¤**ï¼š6ç§ï¼ˆåŒ…æ‹¬é»‘è‰²ç´ ç˜¤ã€åŸºåº•ç»†èƒç™Œç­‰ï¼‰
- **å¤´é¢ˆéƒ¨è‚¿ç˜¤**ï¼š2ç§ï¼ˆå¤´é¢ˆç™Œã€ç”²çŠ¶è…ºç™Œï¼‰
- **ç¥ç»ç³»ç»Ÿè‚¿ç˜¤**ï¼š3ç§ï¼ˆä¸­æ¢ç¥ç»ç³»ç»Ÿç™Œç—‡åŠå„¿ç§‘ç‰ˆæœ¬ï¼‰
- **è½¯ç»„ç»‡åŠéª¨è‚¿ç˜¤**ï¼š4ç§ï¼ˆè½¯ç»„ç»‡è‚‰ç˜¤ã€éª¨ç™Œç­‰ï¼‰
- **å„¿ç§‘è‚¿ç˜¤**ï¼š5ç§ï¼ˆå„¿ç§‘ç™½è¡€ç—…ã€æ·‹å·´ç˜¤ç­‰ï¼‰
- **å…¶ä»–è‚¿ç˜¤**ï¼š7ç§ï¼ˆåŒ…æ‹¬é—´çš®ç˜¤ã€ç¥ç»å†…åˆ†æ³Œè‚¿ç˜¤ç­‰ï¼‰

| åºå· | è‹±æ–‡åç§° | ä¸­æ–‡åç§° | ç‰ˆæœ¬ |
|------|----------|----------|------|
| 1 | ğŸ¯Acute Lymphoblastic Leukemia | æ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—… | 2.2025 |
| 2 | ğŸ¯Acute Myeloid Leukemia | æ€¥æ€§é«“ç³»ç™½è¡€ç—… | 1.2026 |
| 3 | Ampullary Adenocarcinoma | å£¶è…¹éƒ¨è…ºç™Œ | 2.2025 |
| 4 | âœ…Anal Carcinoma | è‚›é—¨ç™Œ | 4.2025 |
| 5 | Basal Cell Skin Cancer | åŸºåº•ç»†èƒçš®è‚¤ç™Œ | 1.2026 |
| 6 | âœ…B-Cell Lymphomas | B ç»†èƒæ·‹å·´ç˜¤ | 3.2025 |
| 7 | Biliary Tract Cancers | èƒ†é“ç™Œ | 2.2025 |
| 8 | Bladder Cancer | è†€èƒ±ç™Œ | 1.2025 |
| 9 | Bone Cancer | éª¨ç™Œ | 1.2026 |
| 10 |âœ… Breast Cancer | ä¹³è…ºç™Œ | 4.2025 |
| 11 | Castleman Disease | å¡æ–¯å°”æ›¼ç—… | 2.2025 |
| 12 | Central Nervous System Cancers | ä¸­æ¢ç¥ç»ç³»ç»Ÿç™Œç—‡ | 2.2025 |
| 13 | ğŸ¯Cervical Cancer | å®«é¢ˆç™Œ | 4.2025 |
| 14 | ğŸ¯Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…/å°æ·‹å·´ç»†èƒæ·‹å·´ç˜¤ | 3.2025 |
| 15 | ğŸ¯Chronic Myeloid Leukemia | æ…¢æ€§ç²’ç»†èƒç™½è¡€ç—… | 1.2026 |
| 16 | Colon Cancer | ç»“è‚ ç™Œ | 4.2025 |
| 17 | Dermatofibrosarcoma Protuberans | éš†çªæ€§çš®è‚¤çº¤ç»´è‚‰ç˜¤ | 1.2026 |
| 18 | Esophageal and Esophagogastric Junction Cancers | é£Ÿç®¡ç™Œå’Œé£Ÿç®¡èƒƒè¿æ¥å¤„ç™Œ | 4.2025 |
| 19 | âœ…Gastric Cancer | èƒƒç™Œ | 3.2025 |
| 20 | Gastrointestinal Stromal Tumors | èƒƒè‚ é“é—´è´¨ç˜¤ | 1.2025 |
| 21 | Gestational Trophoblastic Neoplasia | å¦Šå¨ æ»‹å…»ç»†èƒè‚¿ç˜¤ | 3.2025 |
| 22 | ğŸ¯Hairy Cell Leukemia | æ¯›ç»†èƒç™½è¡€ç—… | 1.2026 |
| 23 | Head and Neck Cancers | å¤´é¢ˆç™Œ | 5.2025 |
| 24 | Hepatobiliary Cancers | è‚èƒ†ç™Œ | 1.2025 |
| 25 | Hepatocellular Carcinoma | è‚ç»†èƒç™Œ | 1.2025 |
| 26 | Histiocytic Neoplasms | ç»„ç»‡ç»†èƒè‚¿ç˜¤ | 1.2025 |
| 27 | âœ…Hodgkin Lymphoma | éœå¥‡é‡‘æ·‹å·´ç˜¤ | 2.2025 |
| 28 | Kaposi Sarcoma | å¡æ³¢è¥¿è‚‰ç˜¤ | 2.2026 |
| 29 | Kidney Cancer | è‚¾ç™Œ | 1.2026 |
| 30 | Melanoma: Cutaneous | é»‘è‰²ç´ ç˜¤ï¼šçš®è‚¤ | 2.2025 |
| 31 | Melanoma: Uveal | é»‘è‰²ç´ ç˜¤ï¼šè‘¡è„è†œ | 1.2025 |
| 32 | Merkel Cell Carcinoma | é»˜å…‹å°”ç»†èƒç™Œ | 1.2026 |
| 33 | Mesothelioma: Peritoneal | é—´çš®ç˜¤ï¼šè…¹è†œ | 2.2025 |
| 34 | Mesothelioma: Pleural | é—´çš®ç˜¤ï¼šèƒ¸è†œ | 2.2025 |
| 35 | Multiple Myeloma | å¤šå‘æ€§éª¨é«“ç˜¤ | 2.2026 |
| 36 | Myelodysplastic Syndromes | éª¨é«“å¢ç”Ÿå¼‚å¸¸ç»¼åˆå¾ | 2.2025 |
| 37 | Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions | ä¼´æœ‰å—œé…¸æ€§ç²’ç»†èƒå¢å¤šå’Œé…ªæ°¨é…¸æ¿€é…¶åŸºå› èåˆçš„é«“ç³»/æ·‹å·´ç»†èƒè‚¿ç˜¤ | 2.2025 |
| 38 | Myeloproliferative Neoplasms | éª¨é«“å¢ç”Ÿæ€§è‚¿ç˜¤ | 2.2025 |
| 39 | ğŸ¯Neuroblastoma | ç¥ç»æ¯ç»†èƒç˜¤ | 1.2025 |
| 40 | Neuroendocrine and Adrenal Tumors | ç¥ç»å†…åˆ†æ³Œå’Œè‚¾ä¸Šè…ºè‚¿ç˜¤ | 2.2025 |
| 41 | âœ…Non-Small Cell Lung Cancer | éå°ç»†èƒè‚ºç™Œ | 8.2025 |
| 42 | Occult Primary | åŸå‘ç¶ä¸æ˜ | 2.2025 |
| 43 | ğŸ¯Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer | åµå·¢ç™Œ/è¾“åµç®¡ç™Œ/åŸå‘æ€§è…¹è†œç™Œ | 3.2025 |
| 44 | âœ…Pancreatic Adenocarcinoma | èƒ°è…ºè…ºç™Œ | 2.2025 |
| 45 | âœ…Pediatric Acute Lymphoblastic Leukemia | å„¿ç«¥æ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—… | 1.2026 |
| 46 | Pediatric Aggressive Mature B-Cell Lymphomas | å„¿ç«¥ä¾µè¢­æ€§æˆç†Ÿ B ç»†èƒæ·‹å·´ç˜¤ | 2.2025 |
| 47 | Pediatric Central Nervous System Cancers | å„¿ç«¥ä¸­æ¢ç¥ç»ç³»ç»Ÿç™Œç—‡ | 3.2025 |
| 48 | âœ…Pediatric Hodgkin Lymphoma | å„¿ç«¥éœå¥‡é‡‘æ·‹å·´ç˜¤ | 2.2025 |
| 49 | Penile Cancer | é˜´èŒç™Œ | 2.2025 |
| 50 | âœ…Primary Cutaneous Lymphomas | åŸå‘æ€§çš®è‚¤æ·‹å·´ç˜¤ | 3.2025 |
| 51 | Prostate Cancer | å‰åˆ—è…ºç™Œ | 2.2026 |
| 52 | Rectal Cancer | ç›´è‚ ç™Œ | 3.2025 |
| 53 | Small Bowel Adenocarcinoma | å°è‚ è…ºç™Œ | 3.2025 |
| 54 | âœ…Small Cell Lung Cancer | å°ç»†èƒè‚ºç™Œ | 2.2026 |
| 55 | Soft Tissue Sarcoma | è½¯ç»„ç»‡è‚‰ç˜¤ | 1.2025 |
| 56 | Squamous Cell Skin Cancer | é³çŠ¶ç»†èƒçš®è‚¤ç™Œ | 1.2026 |
| 57 | Systemic Light Chain Amyloidosis | ç³»ç»Ÿæ€§è½»é“¾æ·€ç²‰æ ·å˜æ€§ | 1.2026 |
| 58 | Systemic Mastocytosis | ç³»ç»Ÿæ€§è‚¥å¤§ç»†èƒå¢å¤šç—‡ | 1.2025 |
| 59 | âœ…T-Cell Lymphomas | T ç»†èƒæ·‹å·´ç˜¤ | 2.2025 |
| 60 | Testicular Cancer | ç¾ä¸¸ç™Œ | 2.2025 |
| 61 | Thymomas and Thymic Carcinomas | èƒ¸è…ºç˜¤å’Œèƒ¸è…ºç™Œ | 2.2025 |
| 62 | ğŸ¯Thyroid Carcinoma | ç”²çŠ¶è…ºç™Œ | 1.2025 |
| 63 | ğŸ¯Uterine Neoplasms | å­å®«è‚¿ç˜¤ | 3.2025 |
| 64 | ğŸ¯Vaginal Cancer | é˜´é“ç™Œ | 5.2025 |
| 65 | ğŸ¯Vulvar Cancer | å¤–é˜´ç™Œ | 1.2025 |
| 66 | WaldenstrÃ¶m Macroglobulinemia/Lymphoplasmacytic Lymphoma | ç“¦å°”ç™»æ–¯ç‰¹ä¼¦å·¨çƒè›‹ç™½è¡€ç—‡/æ·‹å·´æµ†ç»†èƒæ·‹å·´ç˜¤ | 1.2026 |
| 67 | Wilms Tumor (Nephroblastoma) | è‚¾æ¯ç»†èƒç˜¤ï¼ˆå¨å°”å§†æ–¯è‚¿ç˜¤ï¼‰ | 2.2025 ||